Comparison of classification of the severity of hypertension by blood pressure level and by World Health Organization criteria in the prediction of concurrent cardiac abnormalities and subsequent complications in essential hypertension

Journal of Hypertension

Volumn 11, Issue 12, 1993, Pages 1429-1440

  Mensah, George A ^a   Pappas, Thomas W ^a   Koren, Michael J ^a   Ulin, Roy J ^a   Laragh, John H ^a   Devereux, Richard B ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Echocardiography; Essential hypertension; Hemodynamic profile; Left ventricular hypertrophy; Prognosis; World Health Organization

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; ESSENTIAL HYPERTENSION; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; INTERMETHOD COMPARISON; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE; WORLD HEALTH ORGANIZATION;

ADULT; BLOOD PRESSURE; COMPARATIVE STUDY; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGE; MULTIVARIATE ANALYSIS; PROGNOSIS; SUPPORT, U.S. GOV'T, P.H.S.; VENTRICULAR FUNCTION, LEFT; WORLD HEALTH ORGANIZATION;

EID: 0027761385     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199312000-00016     Document Type: Article

References (42)

1. Bresun DJ, Gifford RW, Fairbairn JF: Essential hypertension: twenty-year follow-up study. Circulation 1966, 33:87–97.
2. Kannel WB, Castelli WP, McNamara PM, McKee PA, Feinleib M: Role of blood pressure in the development of congestive heart failure. The Framingham Study. N Engl J Med 1972, 287:781–787.
3. Akinkugbe OO: High Blood Pressure in the African. Edinburgh: Churchill Livingstone; 1972.
4. Svardsudd K, Tibbun G: Mortality and morbidity during 13.5 years’ follow–up in relation to blood pressure. Acta Med Scand 1979, 205:483–492.
5. Sokolow M, Perloff D: The prognosis of essential hypertension treated conservatively. Circulation 1961, 23:697–713.
6. Lew EA: High blood pressure, other risk factors, and longevity. The insurance viewpoint. Am J Med 1972, 55:281–294.
7. Alderman MH: The epidemiology of hypertension: etiology, natural history, and the impact of therapy. Cardiovasc Rev Rep 1980, 1:509–519.
8. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension, III. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation 1972, 45:991–1004.
9. World Health Organization Expert Committee on Arterial Hypertension: Arterial Hypertension. WHO Technical Report Series, no 628. Geneva: WHO; 1978.
10. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure: The fifth report of the Joint National Committee on Detection, Evaluation and Treatment of High Pressures (JNC-V). Arch Intern Med 1993, 153:154–183.
11. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al.: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid event in hypertensive men. Ann Intern Med 1986, 105:173–178.
12. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in men and women with uncomplicated essential hypertension. Ann Intern Med 1991, 114:345–352.
13. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelu WP: Left ventricular mass and incidence of coronary heart disease in an elderly cohort. Ann Intern Med 1989, 110:101–107.
14. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in subjects in the Framingham Heart Study. N Engl J Med 1990, 322:1561–1566.
15. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS: The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992, 117:831–836.
16. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WMF: Mortality associated with dias– tolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988, 77:504–514.
17. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1939, 197:332–343.
18. Sokolow M, Lyon TP: The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads. Am Heart J 1949, 37:161–186.
19. Romhilt DW, Estes EH Jr: A point score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 1968, 75:752–758.
20. Casale PN, Devereux RB, Kligfield P, Eisenberg RR, Miller DH, Chaudhary BS, et al.: Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 1985, 6:572–580.
21. Devereux RB, Ljebson PR, Horan M: Recommendations concerning use of echocardiography in hypertension and general population research. Hypertension 1987, 9:1197–11104.
22. Sahn DJ, DeMaria A, Kisslo J, Weyman A: Recommendations regarding quantitation in M–modc echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58:1072–1083.
23. Reicher N, Devereux RB: Reliable estimation of peak left ventricular systolic pressure by M-modc echographic determined end-diastolic relative wall thickness: identification of severe valvular aortic stenosis in adult patients. Am Heart J 1982, 103:202–209.
24. Savage DD, Garrison RJ, Kannel WB, Levy D, Anderson SJ, Stokes J III, et al.: The spectrum of left ventricular hypertrophy in a general population sample: the Framing– ham Study. Circulation 1987,(suppl I):I26–I33.
25. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613–618.
26. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al.: Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450–458.
27. Devereux RB, Lutas EM, Casale PN, Kugfield P, Eisenberg RR, Hammond IW, et al.: Standardization of M–mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984, 4:1222–1230.
28. Hammond IW, Devereux RB, Alderman MH, Lutas EM, Spitzer MC, Crovcley JS, et al.–. The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol 1986, 7:639–650.
29. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al.: Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol 1992, 19:1550–1558.
30. Reichek N, Wilson J, St John–Sutton M, Plappert TA, Goldberg S, Hirshfeld JW: Non–invasive determination of left ventricular end–systolic stress: validation of the method and initial application. Circulation 1982, 65:99–108.
31. Lutas EM, Devereux RB, Reis G, Alderman MH, Pickering TG, Borer JS, et al.: Increased cardiac performance in mild essential hypertension. Left ventricular mechanics. Hypertension 1985, 7:979–988.
32. Devereux RB: Evaluation of cardiac structure and function by echocardiography and other techniques. In Hypertension: Pathophysiology, Diagnosis, and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:1479–1492.
33. Teichholz LE, Kreulen T, Herman MV, Gorlin R: Problems in echocardiographic volume determinations: echocardiographic–angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976, 37:7–11.
34. Asanoi H, Sasayama S, Kameyama T: Ventriculoarterial coupling in normal and failing heart in humans. Circ Res 1989, 65:83–93.
35. Wallerson DC, Ganau A, Roman MJ, Devereux RB: Measurement of cardiac output by M–mode and two–dimensional echocardiography: application to patients with hypertension. Eur Heart J 1990,(suppl 1):67–78.
36. Koren MJ, Savage DD, Laragh JH, Devereux RB: Relation of hemodynamic parameters to prognosis in essential hypertension [abstract]. Am J Hypertens 1990, 3:13.
37. Dixon WJ, Brown MB, Engelman L, Hill MA, Jennrich RI: Bmdp Statistical Software Manual. Berkeley: University of California Press; 1988.
38. Freis ED: Hemodynamics of hypertension. Physiol Rev 1960, 40:27–54.
39. Lund–Johansen P: The hemodynamics of essential hypertension. In Handbook of Hypertension, vol 1: Clinical Aspects of Essential Hypertension. Edited by Robertson JIS. New York: Elsevier Scientific; 1983:151–172.
40. Sealey JE, Blumenfeld JD, Bell GM, Pecker MS, Sommers SC, Laragh JH: On the renal basis for essential hypertension: nephron heterogeneity with discordant rerun secretion and sodium excretion causing a hypertensive vasoconstriction–volume relationship. In Hypertension: Pathophysiology, Diagnosis, and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:1089–1103.
41. Perloff D, Sokolow M, Cowan RM, Juster RP: Prognostic value of ambulatory blood pressure measurements: further analyses. J Hypertens 1989,(suppl 3):S3–S10.
42. Pickering TG, James GD, Harshfield GA, Blank SG, Cates E, Bohmart A, et al.: Ambulatory monitoring improves prediction of risk in patients with borderline hypertension. In The Society of Behavioral Medicine. Twelfth Annual Proceedings. Rockville, Maryland: Society of Behavioral Medicine; 1991:24–25.